Cerenovus (formerly Neuravi)
AcquiredAdvancing Stroke Therapy
- Headquarters
- Galway
- Employees
- 201–500
- Business Model
- B2B
- Website
- jnjmedtech.com
- Acquisition Date
- Apr 2017
About
Cerenovus is the neurovascular business unit of Johnson & Johnson MedTech, focused on developing and commercializing therapies for the treatment of stroke. Originally founded as Neuravi, an Irish medical device company, it was acquired by Johnson & Johnson and rebranded as Cerenovus to advance the full spectrum of ischemic and hemorrhagic stroke care. The business develops products including thrombectomy devices, detachable coils, and other neurovascular tools, and in 2026 J&J MedTech announced an agreement to divest the Cerenovus business to Medtronic.
Summary
Cerenovus (formerly Neuravi) is a Healthcare company based in Galway, Ireland. Investors include IPF Partners.
Exit History
Apr 2017
Sign up to see all 2 events
Funding, valuations, and company events, with amounts and investors where available.
Investors
Similar Companies
Healthcare cost management company providing data analytics and network-based payment solutions t...
American dietary supplements company owning Nature's Bounty, Solgar, and Puritan's Pride brands; ...
OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...
World-leading Canadian cannabis company cultivating and selling medicinal and recreational cannab...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/cerenovus-formerly-neuravi"><img src="https://indexed.vc/api/badge/company/cerenovus-formerly-neuravi" alt="Cerenovus (formerly Neuravi) on Indexed.vc" width="260" height="76" /></a>